Livio Valenti is a sustainability entrepreneur leveraging scientific discoveries to build innovative companies in the healthcare, biotechnology and material science field.
He is the co-founder of Vaxess Technologies, a biotechnology company developing a new class of vaccines that can be delivered with a silk-based skin patch. These vaccines do not require refrigeration and can be self-administered by patients, regardless of where they live. Vaxess raised more than $60mn in Venture Capital and Public Funding pioneering a new, sustainable model of company creation in collaboration between Venture Capital and the public sector.
Livio is a Forbes 30 under 30 honoree, Wire Magazine Top Innovator under 35, a fellow at the Atlantic Council, a TEDx speaker and an affiliate with the Aspen Institute. Livio was previously an economist at the United Nations in Cambodia, where he worked with farmers to build the foundation of the silk industry in the country. He graduated from the Harvard Kennedy School of Government (USA), Bocconi University (Italy) and Fudan University (China).